- Report
- January 2024
- 150 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- April 2022
- 191 Pages
Global
From €4230EUR$4,450USD£3,554GBP
- Report
- April 2023
- 240 Pages
Global
From €3327EUR$3,500USD£2,795GBP
- Report
- August 2022
- 120 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- June 2023
- 200 Pages
Global
From €7130EUR$7,500USD£5,990GBP
- Report
- June 2022
- 95 Pages
Global
From €3755EUR$3,950USD£3,155GBP
- Report
- April 2023
- 160 Pages
Global
From €4705EUR$4,949USD£3,952GBP
- Report
- October 2023
- 190 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- March 2024
- 200 Pages
Global
From €3945EUR$4,150USD£3,314GBP
- Report
- February 2024
- 110 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- April 2023
- 115 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- April 2023
- 116 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- October 2022
- 81 Pages
Global
From €3323EUR$3,495USD£2,791GBP
- Report
- November 2020
- 36 Pages
Global
From €3798EUR$3,995USD£3,191GBP
- Report
- August 2022
United States
From €1844EUR$1,940USD£1,549GBP
- Report
- August 2022
Global
From €1131EUR$1,190USD£950GBP
- Report
- February 2021
Global
From €2814EUR$2,960USD£2,364GBP
- Report
- August 2024
- 133 Pages
China
From €1711EUR$1,800USD£1,438GBP
- Report
- August 2024
- 101 Pages
China
From €1711EUR$1,800USD£1,438GBP
- Report
- January 2024
- 109 Pages
United States
€3327EUR$3,500USD£2,795GBP

The Asthma Treatment market is composed of a variety of drugs used to treat asthma symptoms. These drugs are divided into two main categories: long-term control medications and quick-relief medications. Long-term control medications are taken daily to reduce inflammation and prevent asthma symptoms. Quick-relief medications are taken as needed to quickly relieve asthma symptoms. Common long-term control medications include inhaled corticosteroids, leukotriene modifiers, and long-acting beta-agonists. Common quick-relief medications include short-acting beta-agonists and anticholinergics.
The Asthma Treatment market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Novartis, Sanofi, and Teva Pharmaceuticals. Show Less Read more